Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure With Preserved Ejection Fraction (ANTHEM-HFpEF) Study

NCT03163030 is registered in ClinicalTrials.gov with Cyberonics, Inc. as lead sponsor.

NCT NCT03163030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03163030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure With Preserved Ejection Fraction (ANTHEM-HFpEF) Study
Lead sponsor
Cyberonics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2021
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure